https://www.selleckchem.com/pr....oducts/troglitazone-
The aim of this study is to present our experience in the management of hormonally active adrenal tumors in children. We did a retrospective chart review of all children with hormonally active adrenal tumors evaluated at the endocrinology clinic and operated at our institution between 1983 and 2019. There were 75 patients included in the study, 58 with adrenocortical tumors (ACTs) and 17 with pheochromocytomas (PCCs). Within the group of patients with ACTs, there were 41 females and 17 males. The mean age was 58.3 (SD 87.9;